Quarterly report pursuant to Section 13 or 15(d)

Net Loss per Common Share (Details)

v3.19.3
Net Loss per Common Share (Details) - shares
 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total of weighted average shares outstanding 18,331,235 17,667,124
Warrants [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total of weighted average shares outstanding 865,364 890,892
Opus warrants to purchase Common Stock [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total of weighted average shares outstanding 1,880,000 1,880,000
Options to Purchase Common Stock [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total of weighted average shares outstanding 1,169,293 1,085,502
Convertible preferred stock [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total of weighted average shares outstanding 1,002,087 1,000,000
Unvested Restricted Stock [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total of weighted average shares outstanding 12,622,881 11,014,596
Unvested Restricted Stock Units [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total of weighted average shares outstanding 791,610 1,796,134